Search

New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward improving options for patients with early-stage, potentially indolent cancers.

… Monday, July 17, 2023 New research from  Memorial Sloan Kettering Cancer Center (MSK)  and the  Sloan Kettering Institute  — a hub for basic science and translational research within MSK — discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers;

Memorial Sloan Kettering hosted its 24th annual “Thrivers” celebration to honor the patients, staff, and caregivers of the MSK Bone Marrow Transplantation (BMT) Service.

… Friday, September 13, 2019 It was a night of long hugs, standing ovations, well-earned tears, and “can you believe it?” stories, as Memorial Sloan Kettering hosted a lavish party to honor the patients, staff, and caregivers of MSK’s renowned Bone Marrow Transplant (BMT) Service . The event marked MSK

Take a look back at some of the year’s biggest news in cancer research.

… Thursday, December 27, 2018 December wouldn’t be complete without a recap of the year’s most important scientific advances in cancer. Memorial Sloan Kettering scientists published hundreds of studies this past year and weighed in as experts on many others. Below are some of the year’s highlights.   1

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.

… Friday, September 29, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising

New research from MSK explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair; reports findings from a clinical trial for people with androgen receptor-positive salivary gland cancer; and aims to understand the impact of tumor mutational burden on patients with locally advanced non-small cell lung cancer.

… Friday, January 20, 2023 New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute — MSK’s experimental research arm — explores novel predictors of immunotherapy effectiveness against lung cancer; identifies how a high-fat diet hinders intestinal damage repair;

Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.

… Monday, April 10, 2017 Summary Some patients who receive immunotherapy drugs called checkpoint inhibitors experience significant benefit in terms of tumor shrinkage and longer survival — but many do not. A new study suggests that measuring changes in the blood could help doctors determine whether a person

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.

… Friday, September 26, 2025 She has helped robots learn to get around indoors and pick up balls from the ground. And she has developed computer programs to monitor traffic at intersections. But these days,  Harini Veeraraghavan, PhD , applies her expertise to fighting cancer. Her lab at Memorial Sloan Kettering

During the pandemic, Dr. John Chodera’s lab shifted gears to help find new drugs against COVID-19. Learn how lessons from the effort are already aiding in the search for new cancer drugs.

… Thursday, January 19, 2023 Update: The COVID Moonshot team formally reported their results in Science in November 2023. The article was accompanied by a perspective titled “ Preparing for the next pandemic .”   A billion billion operations per second — 1 million times faster than a high-end PC and 10

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.

… Wednesday, February 22, 2017 Summary A powerful genome-editing tool called CRISPR allows researchers to precisely modify the DNA of cells. In a first, MSK scientists have now used the technique to build better-functioning CAR T cells for use in cancer immunotherapy. Clinical trials in humans are being

In 2024, patients from more than 70 countries — from Gambia and Japan to Italy and Brazil — came to MSK seeking our medical expertise and compassionate care.

… Friday, June 6, 2025 Memorial Sloan Kettering Cancer Center (MSK) welcomes patients from all over the world for consultation and treatment. Patients have traveled from six continents and more than 100 countries seeking out MSK’s expertise in diagnosing and treating all cancers, including rare and difficult-to-treat